Warburg Pincus scores 3x healthcare exit

An agressive roll out of Euromedic International by Warburg Pincus and its co-investors has trebled the firm's original investment. The company has been sold to Merrill Lynch's private equity group and Ares Life Sciences for some €800m.

PRIVATE CREDIT

Register to unlock this content

• Daily global private credit news and market intelligence
• Expertly curated insights that keep you ahead of the market
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

DealsEurope